A2DMQY Cronos Group Inc

Cronos Group Inc. CEO, Mike Gorenstein, to Speak at the 23rd Annual CIBC Western Institutional Investor Conference

Cronos Group Inc. CEO, Mike Gorenstein, to Speak at the 23rd Annual CIBC Western Institutional Investor Conference

TORONTO, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at the 23rd Annual CIBC Western Institutional Investor Conference on Thursday, January 30, 2020 at 3:15 p.m. MST in Banff, AB.

A recording will be available on the Investors section of the Company’s website at .

About Cronos Group Inc.

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes ™, a global health and wellness platform, two adult-use brands, ™ and ™, and two hemp-derived CBD brands, ™ and ™. For more information about Cronos Group and its brands, please visit:

Forward-Looking Statements

This news release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws. All information contained herein that is not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify forward-looking statements. Some of the forward-looking statements contained in this press release include the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s current Management’s Discussion and Analysis and Annual Information Form, both of which have been filed on SEDAR and EDGAR and can be accessed at  and , respectively. The forward-looking information included in this news release is made as of the date of this news release and, except as required by law, Cronos Group disclaims any obligation to update or revise any forward-looking statements. Readers are cautioned not to put undue reliance on these forward-looking statements.

Cronos Group Contact

Anna Shlimak

Tel: (416) 504-0004

EN
23/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos to enter the Netherlands with acquisition of Europe’s largest a...

Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027 Up-front consideration represents approximately 1.4x CanAdelaar LTM revenue and 2.4x LTM EBITDA2 Will give Cronos #1 market share3 in the largest adult-use cannabis market in Europe Enables borderless product strategy, leveraging investments in genetics, R&D, and product development TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON)...

 PRESS RELEASE

Cronos Launches Premium Lord Jones Live Resin Fusions™ in Canada

Cronos Launches Premium Lord Jones Live Resin Fusions™ in Canada TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced is expanding its portfolio for its Lord Jones® brand with new innovations designed to enhance its lineup of premium cannabis products in the Canadian market. The new Lord Jones Live Resin Fusions™ pre-rolls combine top-tier craftsmanship with exceptional cannabis genetics, reflecting the brand’s continued dedication to quality and refinement. The Lord ...

 PRESS RELEASE

Cronos Group Reports 2025 Third Quarter Results

Cronos Group Reports 2025 Third Quarter Results Achieved record levels of consolidated net revenue, gross profit and Adjusted EBITDA Net revenue in Q3 2025 increased by 9% quarter-over-quarter and 6% year-over-year Generated record-high net revenue in Israel, where PEACE NATURALS® remains the number one cannabis brand1 Industry-leading balance sheet with $824 million in total cash and cash equivalents and short-term investments TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 third quarter bus...

 PRESS RELEASE

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavo...

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced today that it is welcoming back its limited-edition Caramel Green Apple flavor to its best-selling lineup of SOURZ by Spinach® edibles for the fall and Halloween season. The return of this popular and limited-edition product, which features buttery, sweet caramel and tart-green apple flavors and is perfect for the autumn months, follows i...

 PRESS RELEASE

Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call ...

Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025 TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage part...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch